Andrey Ivanov, PhD
-
Research Program
-
Phone Number
-
Email Address
Biography
Andrey Ivanov, PhD, is an assistant professor in the Department of Pharmacology and Chemical Biology at Emory University School of Medicine and team lead for computational chemical biology and systems pharmacology at Emory Chemical Biology Discovery Center.
Dr. Ivanov is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute of Emory University.
Education
Dr. Ivanov received his PhD in Organic and Computational Chemistry from Institute of Physiologically Active Compounds of the Russian Academy of Sciences in Russia.
Titles & Roles
-
Assistant Professor, Department of Pharmacology and Chemical BiologyEmory University School of Medicine
Research
Dr. Ivanov's research focuses on computational chemical biology and systems pharmacology to identify cancer targets and chemical probes.
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
The Journal of clinical investigation |
Y Zhu, A Banerjee, P Xie, AA Ivanov, A Uddin, Q Jiao, JJ Chi, L Zeng, JY Lee, Y Xue, X Lu, M Cristofanilli, WJ Gradishar, CJ Henry, TW Gillespie, MA Bhave, K Kalinsky, H Fu, I Bahar, B Zhang, Y Wan | 26/03/2024 |
|
The Journal of biological chemistry |
Y Du, WJ Bradshaw, TM Leisner, JK Annor-Gyamfi, K Qian, FM Bashore, A Sikdar, FO Nwogbo, AA Ivanov, SV Frye, O Gileadi, PE Brennan, AI Levey, AD Axtman, KH Pearce, H Fu, VL Katis | 01/12/2023 |
|
TMPRSS2 and SARS-CoV-2 SPIKE interaction assay for uHTS. Journal of molecular cell biology |
D Cicka, Q Niu, M Qui, K Qian, E Miller, D Fan, X Mo, AA Ivanov, SG Sarafianos, Y Du, H Fu | 03/08/2023 |
|
Evaluation of software impact designed for biomedical research: Are we measuring what's meaningful? ArXiv |
A Afiaz, AA Ivanov, J Chamberlin, D Hanauer, CL Savonen, MJ Goldman, M Morgan, M Reich, A Getka, A Holmes, S Pati, D Knight, PC Boutros, S Bakas, JG Caporaso, G Del Fiol, H Hochheiser, B Haas, PD Schloss, JA Eddy, J Albrecht, A Fedorov, L Waldron, AM Hoffman, RL Bradshaw, JT Leek, C Wright | 05/06/2023 |
|
bioRxiv : the preprint server for biology |
Y Du, WJ Bradshaw, TM Leisner, JK Annor-Gyamfi, K Qian, FM Bashore, A Sikdar, FO Nwogbo, AA Ivanov, SV Frye, O Gileadi, PE Brennan, AI Levey, AD Axtman, KH Pearce, H Fu, VL Katis | 22/05/2023 |
|
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells. Acta pharmacologica Sinica |
C Shu, X Zheng, A Wuhafu, D Cicka, S Doyle, Q Niu, D Fan, K Qian, AA Ivanov, Y Du, X Mo, H Fu | 01/09/2022 |
|
Systematic discovery of mutation-directed neo-protein-protein interactions in cancer. Cell |
X Mo, Q Niu, AA Ivanov, YH Tsang, C Tang, C Shu, Q Li, K Qian, A Wahafu, SP Doyle, D Cicka, X Yang, D Fan, MA Reyna, LAD Cooper, CS Moreno, W Zhou, TK Owonikoko, S Lonial, FR Khuri, Y Du, SS Ramalingam, GB Mills, H Fu | 26/05/2022 |
|
Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer. Bioorganic & medicinal chemistry |
X Yang, D Fan, AH Troha, HM Ahn, K Qian, B Liang, Y Du, H Fu, AA Ivanov | 01/09/2021 |
|
Cell chemical biology |
C Tang, X Mo, Q Niu, A Wahafu, X Yang, M Qui, AA Ivanov, Y Du, H Fu | 20/05/2021 |
|
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer |
TK Owonikoko, B Dwivedi, Z Chen, C Zhang, B Barwick, V Ernani, G Zhang, M Gilbert-Ross, J Carlisle, FR Khuri, WJ Curran, AA Ivanov, H Fu, S Lonial, SS Ramalingam, SY Sun, EK Waller, GL Sica | 01/03/2021 |
|
Journal of translational medicine |
X Yang, M Amgad, LAD Cooper, Y Du, H Fu, AA Ivanov | 01/09/2020 |
|
NSD3S stabilizes MYC through hindering its interaction with FBXW7. Journal of molecular cell biology |
V Gonzalez-Pecchi, AK Kwan, S Doyle, AA Ivanov, Y Du, H Fu | 03/07/2020 |
|
Online informatics resources to facilitate cancer target and chemical probe discovery. RSC medicinal chemistry |
X Yang, H Fu, AA Ivanov | 01/06/2020 |
|
Explore Protein-Protein Interactions for Cancer Target Discovery Using the OncoPPi Portal. Methods in molecular biology (Clifton, N.J.) |
AA Ivanov | 01/01/2020 |
|
Hybrid Au/Si Disk-Shaped Nanoresonators on Gold Film for Amplified SERS Chemical Sensing. Nanomaterials (Basel, Switzerland) |
G Barbillon, A Ivanov, AK Sarychev | 08/11/2019 |
|
Protein Phosphatase 1-Targeting Small-Molecule C31 Inhibits Ebola Virus Replication. The Journal of infectious diseases |
T Ammosova, CA Pietzsch, Y Saygideger, A Ilatovsky, X Lin, A Ivanov, N Kumari, M Jerebtsova, A Kulkarni, M Petukhov, A Üren, A Bukreyev, S Nekhai | 22/11/2018 |
|
In vivo screening identifies GATAD2B as a metastasis driver in KRAS-driven lung cancer. Nature communications |
CL Grzeskowiak, ST Kundu, X Mo, AA Ivanov, O Zagorodna, H Lu, RH Chapple, YH Tsang, D Moreno, M Mosqueda, K Eterovic, JJ Fradette, S Ahmad, F Chen, Z Chong, K Chen, CJ Creighton, H Fu, GB Mills, DL Gibbons, KL Scott | 16/07/2018 |
|
RON kinase inhibition reduces renal endothelial injury in sickle cell disease mice. Haematologica |
A Khaibullina, EA Adjei, N Afangbedji, A Ivanov, N Kumari, LEF Almeida, ZMN Quezado, S Nekhai, M Jerebtsova | 01/05/2018 |
|
Bioinformatics (Oxford, England) |
AA Ivanov, B Revennaugh, L Rusnak, V Gonzalez-Pecchi, X Mo, MA Johns, Y Du, LAD Cooper, CS Moreno, FR Khuri, H Fu | 01/04/2018 |
|
Assay and drug development technologies |
J Xiong, VG Pecchi, M Qui, AA Ivanov, X Mo, Q Niu, X Chen, H Fu, Y Du | 01/01/2018 |
|
Oncotarget |
X Lin, N Kumari, C DeMarino, YS Kont, T Ammosova, A Kulkarni, M Jerebtsova, G Vazquez-Meves, A Ivanov, K Dmytro, A Üren, F Kashanchi, S Nekhai | 29/09/2017 |
|
Molecular pharmacology |
X Mo, Q Qi, AA Ivanov, Q Niu, Y Luo, J Havel, R Goetze, S Bell, CS Moreno, LA Cooper, MA Johns, FR Khuri, Y Du, H Fu | 01/04/2017 |